Congress calls for review of alleged conflicts by FDA official

Recent concerns have prompted an official request for an investigation into potential conflicts of interest involving a senior FDA medical device official, Dr. Jeffrey Shuren, and his wife’s legal activities. Dr. Shuren, who is set to retire from the Food and Drug Administration later this year, has faced scrutiny over his professional actions, which may have coincided with his wife Allison Shuren’s legal representation of medical device firms.

Christina Jewett reports that Representatives Anna Eshoo from California and Rosa DeLauro from Connecticut have officially called on the inspector general to examine these potential ethical conflicts. Both lawmakers, influential members of key health and appropriations subcommittees, acted after revelations from an investigative report highlighted the possible overlap of professional duties and personal interests within the Shuren household.

This inquiry centers on Allison Shuren, who co-chairs the drug and medical device sector at a notable law firm in Washington, D.C., Arnold & Porter, and her representation of companies that her husband’s agency directly regulates. The situation presents a complex scenario of intertwined professional responsibilities that could pose risks of bias or improper influence in regulatory practices.

The investigation aims to ensure transparency and integrity in the regulatory processes that govern critical medical devices such as pacemakers and artificial hips, safeguarding public trust in the oversight conducted by the FDA.